Khiron Pharma Commerce ApS Financials, key figures and credit report
Gross profit 780.4 kDKK FY 2025 +193.2% vs 2024
EBIT 446.5 kDKK FY 2025 +2,999.8% vs 2024
Net debt - 184.2 kDKK FY 2025 -46.5% vs 2024
Quick ratio 1.8 FY 2025 -1.3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 129.59 | -60.98 | 154.05 | 266.13 | 780.43 |
| Employee benefit expenses | -42.75 | -0.15 | - 240.93 | - 309.32 | |
| Total depreciation | -10.80 | -24.64 | |||
| EBIT | 86.83 | -61.13 | 154.05 | 14.40 | 446.47 |
| Other financial income | 0.04 | 0.32 | 0.06 | ||
| Other financial expenses | -28.29 | -1.00 | -5.62 | -7.17 | |
| Pre-tax profit | 58.54 | -62.13 | 154.09 | 9.10 | 439.36 |
| Income taxes | -3.96 | -20.28 | -4.86 | -99.72 | |
| Net earnings | 54.58 | -62.13 | 133.81 | 4.24 | 339.64 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 112.40 | 87.76 | |||
| Tangible assets total | 112.40 | 87.76 | |||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 6.86 | 80.49 | |||
| Inventories total | 6.86 | 80.49 | |||
| Current trade debtors | 179.11 | 1.01 | 1.01 | 228.59 | |
| Prepayments and accrued income | 2.83 | 8.44 | 13.44 | ||
| Current other receivables | 25.16 | 384.78 | 384.76 | 244.47 | 587.91 |
| Short term receivables total | 204.27 | 388.63 | 385.77 | 481.50 | 601.36 |
| Cash and bank deposits | 19.65 | 13.23 | 177.36 | 125.72 | 184.15 |
| Cash and cash equivalents | 19.65 | 13.23 | 177.36 | 125.72 | 184.15 |
| Balance sheet total (assets) | 230.78 | 401.86 | 563.14 | 719.62 | 953.76 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | -4.93 | 49.65 | -12.48 | 121.33 | 125.57 |
| Profit of the financial year | 54.58 | -62.13 | 133.81 | 4.24 | 339.64 |
| Shareholders equity total | 99.65 | 37.52 | 171.33 | 175.57 | 515.21 |
| Provisions | 4.40 | 4.06 | |||
| Non-current liabilities total | |||||
| Advances received | 342.36 | ||||
| Short-term deferred tax liabilities | 3.96 | 20.28 | 0.46 | 96.06 | |
| Other non-interest bearing current liabilities | 127.17 | 364.34 | 371.52 | 196.82 | 338.44 |
| Current liabilities total | 131.13 | 364.34 | 391.80 | 539.65 | 434.49 |
| Balance sheet total (liabilities) | 230.78 | 401.86 | 563.14 | 719.62 | 953.76 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated